J Korean Pain Soc.  1994 Nov;7(2):282-286.

Two Cases Report of Epidural Clonidine Analgesia in Cancer Patient and in Patient Tolerant to Opioids

Affiliations
  • 1Department of Anesthesiology, College of Medicine, Hallym University, Kangwon, Korea.

Abstract

The central antihypertensive agent clonidine is an a2,-adrenergic agonist that possesses painrelieving properties. It has been administered epidurally in the treatment of cancer pain and for postoperative analgesia. 1) Case l, 62-year-old woman who suffered from neurogenic pain syndrome due to metastatic squamous cell carcinoma of spinal canal was treated. 2) Case 2, 51-year-old woman undergoing lower aMominal surgery, epidurally administered morphine did not produced postoperative analgesia. In these cases, continuous epidural administeration of clonidine (200ug/day) and 0.3% bupivacaine (12 ml/day) produce high quality pain relief. These results suggest that antinociceptive effect of epidural clonidine is assumed to result from activation of a-adrenergic receptors in the dorsal horn of the spinal cord.

Keyword

Epidural clonidine

MeSH Terms

Analgesia*
Analgesics, Opioid*
Animals
Bupivacaine
Carcinoma, Squamous Cell
Clonidine*
Female
Horns
Humans
Middle Aged
Morphine
Spinal Canal
Spinal Cord
Analgesics, Opioid
Bupivacaine
Clonidine
Morphine
Full Text Links
  • KJP
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr